Welcome to our dedicated page for Progyny news (Ticker: PGNY), a resource for investors and traders seeking the latest updates and insights on Progyny stock.
Progyny, Inc. reports developments in women's health and family building benefits, including fertility care access, employer demand, product expansion, and financial results. The company provides benefit solutions for employers, health plans, and benefit purchasers, combining concierge support, coaching, education, digital tools, and access to a network of fertility and women's health specialists.
Recurring updates include quarterly earnings, financial guidance, selling-season activity, share repurchases, investor conference appearances, and offerings such as Progyny Select, a fully insured supplemental fertility and family building plan for small U.S. employers.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Progyny, Inc. (Nasdaq: PGNY) will report its financial results for the quarter ending March 31, 2023, on May 8, 2023, after market close. The company will host a conference call at 4:45 PM ET to discuss these results. Interested participants can access the call by dialing specific numbers provided for U.S. and international participants using the passcode 265484. An audio replay will be available until May 15, 2023. Progyny specializes in fertility benefits management, offering comprehensive solutions that include education, access to specialists, and cost reduction for employers. The company has received recognition from several reputable organizations for its growth and leadership in the healthcare sector.
Progyny, Inc. (Nasdaq: PGNY), a leader in fertility benefits management, is partnering with RESOLVE: The National Infertility Association to raise awareness during National Infertility Awareness Week 2023. This includes lighting the Empire State Building in orange and ringing the Nasdaq Closing Bell on April 25, 2023. The CDC reports that 1 in 5 married women in the U.S. face infertility issues, highlighting the struggles many endure to build families. Progyny’s CEO, Pete Anevski, emphasizes the company’s commitment to supporting individuals facing infertility, with successful outcomes for tens of thousands so far. The ceremony aims to amplify this message, reaching audiences beyond New York City. Celebrities like Adrienne Bailon-Houghton are also involved, advocating for increased access to family building care. This collaboration reflects a significant step in addressing infertility stigma.
Progyny, Inc. (Nasdaq: PGNY) recently appointed Dr. Janet Choi as Chief Medical Officer, leveraging over 20 years of experience in reproductive health. Formerly the Medical Director at CCRM New York, Dr. Choi will advance the company’s clinical strategy in family building benefits. Her leadership aims to enhance quality and effectiveness in care, emphasizing the importance of inclusive employer-sponsored benefits. Dr. Choi is a recognized expert, having been featured in New York Magazine’s Top Doctors and Castle Connolly’s 'Top Doctors.' This strategic addition signals Progyny's commitment to pioneering solutions in women's health and fertility benefits.